In-Licensing

Expanding commercial opportunities through in-licensing is an important complement to Rimon Therapeutics' core development activities and part of our strategy to be the global Theramer® patent house.

If you have a biomaterial technology that you think would be of interest to Rimon Therapeutics, please contact info@rimontherapeutics.com with a brief description of the technology or a request for a non-disclosure agreement.

"Rimon aims to create a global Theramer® brand through aggresive invention, in-licensing and strategic acquisition."
Dr. Michael H. May, PhD, President, Director

For more events and discussion, please visit our blog site at: http://rimon.blogware.com